Heart Transplant Program, St Vincent's Hospital, Sydney, NSW Australia.
School of Medicine, Notre Dame, Sydney, NSW Australia.
Transplantation. 2022 Jan 1;106(1):200-209. doi: 10.1097/TP.0000000000003669.
The aim of this study was to validate our previous finding that frailty predicts early mortality in patients with advanced heart failure (AHF) and that including cognition in the frailty assessment enhances the prediction of mortality.
Patients with AHF referred to our Transplant Unit between November 2015 and April 2020 underwent physical frailty assessment using the modified Fried physical frailty (PF) phenotype as well as cognitive assessment using the Montreal Cognitive Assessment to identify patients who were cognitively frail (CogF). We assessed the predictive value of the 2 frailty measures (PF ≥ 3 of 5 = frail; CogF ≥ 3 of 6 = frail) for pretransplant mortality.
Three hundred thirteen patients (233 male and 80 female; age 53 ± 13 y) were assessed. Of these, 224 patients (72%) were nonfrail and 89 (28%) were frail using the PF. The CogF assessment identified an additional 30 patients as frail: 119 (38%). Frail patients had significantly increased mortality as compared to nonfrail patients. Ventricular assist device and heart transplant-censored survival at 12 mo was 92 ± 2 % for nonfrail and 69 ± 5% for frail patients (P < 0.0001) using the CogF instrument.
This study validates our previously published findings that frailty is prevalent in patients with AHF referred for heart transplantation. PF predicts early mortality. The addition of cognitive assessment to the physical assessment of frailty identifies an additional cohort of patients with a similarly poor prognosis.
本研究旨在验证我们之前的发现,即虚弱预测晚期心力衰竭(AHF)患者的早期死亡率,并且在虚弱评估中纳入认知可以增强对死亡率的预测。
2015 年 11 月至 2020 年 4 月,我们的移植科收治的 AHF 患者接受了改良的 Fried 身体虚弱(PF)表型的身体虚弱评估以及使用蒙特利尔认知评估来识别认知虚弱(CogF)的认知评估。我们评估了这两种虚弱测量方法(PF≥5 项中的 3 项=虚弱;CogF≥6 项中的 3 项=虚弱)对移植前死亡率的预测价值。
对 313 名患者(233 名男性和 80 名女性;年龄 53±13 岁)进行了评估。其中,224 名患者(72%)使用 PF 是非虚弱的,89 名(28%)是虚弱的。CogF 评估另外确定了 30 名虚弱患者:119 名(38%)。与非虚弱患者相比,虚弱患者的死亡率显著增加。使用 CogF 仪器,非虚弱患者和虚弱患者的 12 个月时心室辅助装置和心脏移植的生存情况分别为 92±2%和 69±5%(P<0.0001)。
本研究验证了我们之前发表的发现,即虚弱在接受心脏移植的 AHF 患者中很常见。PF 预测早期死亡率。在身体虚弱评估中加入认知评估,可以识别出另一组预后同样不佳的患者。